QDEL: QuidelOrtho Corporation
Performance
QDEL -40.59%
Watchlist
Select an item
Summary
QDEL at a glance
QDEL returned -40.59% over the past year and -36.85% a year over five years. Its worst drop in that year was -71.85%, smaller than 5% of stocks on Redstone, and its Sharpe ratio of -0.15 beats 21% of stocks on Redstone. It pays no dividends.
Current Drawdown
-65.83%
Rolling Volatility
102.30%
Actions
Metrics
Risk Indicators
Alpha-38.47%
Beta2.51x
Sharpe-0.15
Sortino-0.21
Omega0.97
Calmar-0.56
Martin-0.27
Profile
About QDEL
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe.
- Sector
- Health Care
- Industry
- In Vitro & in Vivo Diagnostic Substances
- Market cap
- $830M
- Listed
- Aug 1981
- Employees
- 6,500
- Headquarters
- San Diego, CA
- Website
- quidelortho.com
Comparisons